Atlas Trials

Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Clinical trial NCT05653531 · WITHDRAWN

Trial details

NCT number
NCT05653531
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Immune Checkpoint InhibitorLung CancerLiver BiomarkersTransaminases
Start date
2022-10-25
Primary completion
2023-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.